- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03807830
Exploring the Use of ECochG Testing During Electrode Insertion in Cochlear Implant Surgery
Investigation of a new ECoChG system (Electrocochleography) during the surgical insertion of cochlear implants, for patients with Advanced Bionics devices.
The sound recordings created may be useful in aiding the surgeon to better implant the patient by letting him or her know if they are damaging the ear during implantation in real time
Patients will be followed up for 1 year post surgery within our trial, and have a further 3 ECochGs performed in the clinic setting, (6 weeks, 6 months, 1 year) through their implants.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cochlear implant candidature has changed in the past years. Today many cochlear implant recipients have some low frequency residual hearing in the ear which is to be implanted. To help preserve hearing, the electrode array must be inserted extremely carefully. It is desirable to have real-time feedback relating to progress of the electrode insertion.
One possible tool that might provide this is an electrocochleography (ECochG). A brief low-frequency acoustic tone at a fixed level is delivered to the external ear canal. This results in normal movements of the outer and the inner hair cells inside the inner ear. These movements are known to produce small electrical potentials that have been previously been sensed by a recording electrode placed on the promontory, or surface of the bone in which the cochlea is located. Averaging of these recordings in synchrony with the acoustic stimulus allows the small ECochG signal to be reinforced while any physiological or electrical noise is averaged out. With ECochG measurements different aspects of the auditory system can be tested. For the investigators work only the cochlear microphonic, generated by the outer hair cells will be recorded and analysed.
The Advanced Bionics (AB) implant system is uniquely suited to do such measurements. The aim of the study is to monitor electrode array insertion during surgery and any residual hearing function over time in using this tool as a comparison to conventional methods. Subjects will undergo the study procedure of ECochG measurements, alongside additional standard of care appointments for the research, pure tone audiometry and impedence measurement. Only a 10 minute ECochG measurement will be the additional research component to the patients clinical routine as mentioned above.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cambridge, United Kingdom
- Addenbrookes Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients between ages of 12 months to 6 years old, and Adults over 18 years old
- Meets normal candidacy requirements for cochlear implantation
- Advanced Bionics (AB) implant has been selected for patient at MDT
- Patient has capacity to consent
- Patent cochlea as verified by CT or MRI scan
- No cochlear abnormality that might prevent insertion of the electrode array
- Measurable residual hearing in the ear to be implanted
- No additional handicap that would prevent study procedures being followed
- Agreement to participate in the study
Exclusion Criteria:
- Complex cases where minimal duration of surgery is required. Although ECochG adds less than 10 minutes to the surgery time.
- Patients lacking the capacity to consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: One arm feasbility study
|
Intra-operative ECochG recording via the implant, post operative ECochG measurements.
Impedances measured over time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure cochlear micro phonic amplitude
Time Frame: 12 months
|
To measure objectively the cochlear micro phonic amplitude either intra or post operatively within initial 12 months of cochlear implant use
|
12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Manohar L Bance, MD, The Emmeline Centre for Cochlear Implants
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 18/EE/0304
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cochlear Implants
-
Centre Hospitalier Universitaire DijonCompletedUnilateral Cochlear Implants | Bilateral Cochlear ImplantsFrance
-
MED-EL Elektromedizinische Geräte GesmbHNot yet recruiting
-
MED-EL Elektromedizinische Geräte GesmbHHannover Medical SchoolCompleted
-
Advanced Bionics AGCompletedCochlear ImplantsFrance
-
Hospices Civils de LyonRecruiting
-
Father Flanagan's Boys' HomeCompletedCochlear ImplantsUnited States
-
Hospices Civils de LyonCompletedCochlear ImplantsFrance
-
MED-EL Elektromedizinische Geräte GesmbHCompleted
-
Sophie McKennyUniversity of CambridgeEnrolling by invitationCochlear ImplantsUnited Kingdom
-
Hospices Civils de LyonCompletedCochlear ImplantsFrance